Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.
Gibbs
Peter
P
Department of Medical Oncology and Haematology, Royal Melbourne Hospital, Parkville, Melbourne, Australia.
Clingan
Philip R
PR
Ganju
Vinod
V
Strickland
Andrew H
AH
Wong
Shirley S
SS
Tebbutt
Niall C
NC
Underhill
Craig R
CR
Fox
Richard M
RM
Clavant
Steven P
SP
Leung
Jenny
J
Pho
Minh
M
Brown
Tracey J
TJ